Asset Management One’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-43,575
| Closed | -$1.16M | – | 1060 |
|
2016
Q3 | $1.16M | Hold |
43,575
| – | – | 0.02% | 794 |
|
2016
Q2 | $961K | Sell |
43,575
-3,527
| -7% | -$77.8K | 0.01% | 852 |
|
2016
Q1 | $1.38M | Hold |
47,102
| – | – | 0.02% | 757 |
|
2015
Q4 | $1.56M | Hold |
47,102
| – | – | 0.02% | 704 |
|
2015
Q3 | $1.7M | Buy |
47,102
+21,494
| +84% | +$777K | 0.03% | 672 |
|
2015
Q2 | $1.15M | Buy |
+25,608
| New | +$1.15M | 0.02% | 837 |
|
2015
Q1 | – | Sell |
-12,546
| Closed | -$647K | – | 1350 |
|
2014
Q4 | $647K | Buy |
12,546
+567
| +5% | +$29.2K | 0.01% | 976 |
|
2014
Q3 | $477K | Sell |
11,979
-3,383
| -22% | -$135K | 0.01% | 1029 |
|
2014
Q2 | $682K | Buy |
15,362
+1,862
| +14% | +$82.7K | 0.01% | 875 |
|
2014
Q1 | $525K | Buy |
13,500
+8,714
| +182% | +$339K | 0.01% | 906 |
|
2013
Q4 | $134K | Buy |
+4,786
| New | +$134K | ﹤0.01% | 1084 |
|